Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
Latently infected cells harbor the HIV-1 proviral DNA genome primarily integrated into heterochromatin, allowing the persistence of transcriptionally silent proviruses. Hypoacetylation of histone p...
Meeting Era Biology at ECCMID 2023
The ECCMID congress, the Annual Congress of Clinical Microbiology and Infectious Diseases, is one of the most important events in the field of clinical microbiolo...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
Work Tenaciously, Pursuit Excellence
Genobio Tries to Be a Brave Pathpaver
On December 5th,2015, the marketing management team of Era Biology held an outdoor training.
Every member of this team nee...